Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. - Test2 - elhamkhani - TriplyDB

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.

http://www.wikidata.org/entity/Q34237680

about

Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement Maternal microchimerism: friend or foe in type 1 diabetes?Type 1 diabetes The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes Concise review: pancreas regeneration: recent advances and perspectives The streetlight effect in type 1 diabetes Insulitis in human type 1 diabetes: a comparison between patients and animal models Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?Type 1 diabetes mellitus.Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes.Ongoing beta-cell turnover in adult nonhuman primates is not adaptively increased in streptozotocin-induced diabetes Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data Localization of nucleic acid-sensing toll-like receptors in human and mouse pancreas.Recurrence of autoimmunity following pancreas transplantation.The negative cell cycle regulators, p27(Kip1), p18(Ink4c), and GSK-3, play critical role in maintaining quiescence of adult human pancreatic β-cells and restrict their ability to proliferate.Metabolic abnormalities in the pathogenesis of type 1 diabetes.Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes A human islet cell culture system for high-throughput screening.Mig6 haploinsufficiency protects mice against streptozotocin-induced diabetes Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation.Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.Serum levels of pancreatic stone protein (PSP)/reg1A as an indicator of beta-cell apoptosis suggest an increased apoptosis rate in hepatocyte nuclear factor 1 alpha (HNF1A-MODY) carriers from the third decade of life onward.Stem cell-based strategies for the treatment of type 1 diabetes mellitus Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy.Type 1 diabetes and polyglandular autoimmune syndrome: A review Insulitis in human type 1 diabetes: The quest for an elusive lesion.Immune intervention in type 1 diabetes.Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes.Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetes.Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.Intravital imaging of CTLs killing islet cells in diabetic mice Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.Evidence for Residual and Partly Reparable Insulin Secretory Function and Maintained β-Cell Gene Expression in Islets From Patients With Type 1 Diabetes Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans.Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes.Thinking bedside at the bench: the NOD mouse model of T1DM.Heterogeneity and Lobularity of Pancreatic Pathology in Type 1 Diabetes during the Prediabetic Phase

P2860

Q24600478-660A2C50-4CB8-4A9B-B5BA-B69095910CB6 Q26769878-8892A7D6-D195-4C46-8915-BD38836014CF Q26851151-EE276863-EA48-4DDB-B8DE-F832D194EB77 Q27000491-49BDAEF6-12FB-4131-8D87-B50AF01BB9C9 Q27009048-753B9072-7159-4AB6-9B48-E7475261400D Q27009104-DC5C96ED-790A-4813-8D80-4857E669009D Q27013646-B63DEFD3-9D7C-4D6F-9BAE-FF48294314E5 Q27023064-A94406FA-AEAB-4CE1-AFB8-54965DAA6ED4 Q27023712-7976F5DB-DC27-403F-836D-1F9E27399C66 Q28081034-50EF2A81-C12D-4172-B577-99EDA715F1BA Q30235021-A4F00991-7C74-4D93-9A1B-D3CFDB13DA31 Q30300266-87FF0689-5845-40C3-9692-14E524091E37 Q30498295-B24B817F-82CB-4727-AFF6-A6BAB178CAD5 Q30521476-A0ADFFAB-2FD4-4F63-A7F8-DB3B748A94A6 Q33364494-F3D9FE0C-A3F9-46BE-B55A-DA08208D1A86 Q33599426-25A227DE-EE5F-4CC3-B257-A1D75E50FA77 Q33728087-378A7AAA-0A66-4EE6-9E4A-9CDF95C08950 Q33940335-5ADB39C3-CE8E-496F-853D-74D8491E0CE6 Q33960253-C4AAED71-3D42-463F-A48A-D4E80E74175A Q34095981-A560C7EB-3917-4814-AD13-06163E1173F1 Q34143192-AD26C74F-7763-473E-B8AB-2E643D1E2FF4 Q34207348-A24456DD-249F-4051-B734-846B868788BE Q34240416-E8820A6A-03FB-48F1-8536-1E46F921D9AD Q34244112-0AC12D8C-11A7-42E7-A088-82E2382B7038 Q34342677-25665BAD-FCCC-4980-A3DA-9CD7D4080CE5 Q34417324-5ECF5098-019E-4EE6-9101-D1C6F95AC308 Q34485165-6C440FFC-0F4C-4DDA-AF83-1E783D4D78EC Q35049889-88B9627E-3105-4B43-BF1C-5E941E65FB39 Q35159105-2FD7C05E-F9BD-4A74-A138-87B7F3A431DA Q35226251-1B99513B-CDC3-42EB-9625-2ED2AED16F1D Q35405076-389A5B17-6E89-4C6C-9E4D-FACC8EC46F32 Q35561048-EE6550D6-173E-40EC-85E3-DD15514B526D Q35630698-C4A8480C-4682-485C-A410-E889A605D237 Q35640620-B44CDFAA-37E6-4BB2-B366-9E4CC45F27B6 Q35716720-61E5FB17-34BE-4F2C-A6FF-EF7FF47FB893 Q35769558-3878D05C-1EE4-4F66-A29D-FD410D50C211 Q35803552-56E51288-0690-45A2-BDCB-196D8973A1E1 Q35851405-22AFFFE3-18EF-451C-B898-9901C780ADD8 Q35911875-9E9BAB78-7E3D-4C32-91D9-FAC422DCB286 Q35932766-21AF691B-A9C0-41EF-ABA3-CC80D947FAE6

P2860

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.

http://www.wikidata.org/entity/Q34237680

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Residual insulin production an ...... abetes: Joslin Medalist Study.

@ast

Residual insulin production an ...... abetes: Joslin Medalist Study.

@en

Residual insulin production an ...... abetes: Joslin Medalist Study.

@nl

type

label

Residual insulin production an ...... abetes: Joslin Medalist Study.

@ast

Residual insulin production an ...... abetes: Joslin Medalist Study.

@en

Residual insulin production an ...... abetes: Joslin Medalist Study.

@nl

prefLabel

Residual insulin production an ...... abetes: Joslin Medalist Study.

@ast

Residual insulin production an ...... abetes: Joslin Medalist Study.

@en

Residual insulin production an ...... abetes: Joslin Medalist Study.

@nl

P1433

Q34237680-9DED4956-AFF3-4299-AE88-F1078D555E3C

P1476

Q34237680-9373C378-9762-4676-94C8-CCE94101E2B1

P2093

Q34237680-09FC4D86-954A-49A0-A260-7CB3E5F9A9B3

Q34237680-0FABD1F0-55D0-498C-81F0-86285DF69F84

Q34237680-115DC9D9-62A7-462A-98A0-FBF904700FA5

Q34237680-3188ED97-F8E7-4D9A-AFCF-D01F0AFC3E06

Q34237680-3B9074C8-620E-4863-8C42-9EB0D6FB1A01

Q34237680-56E3B3A8-3F98-47B9-9AD6-B739452AC052

Q34237680-5E135D65-F5DC-47EF-87BF-0D5672C69A19

P2860

Q34237680-10956506-543C-48AE-AE9E-0158FF3C1BF4

Q34237680-1B9C2AB6-588C-4899-84F7-346E67354ED8

Q34237680-46E0E0C5-E491-48C6-9961-E7752DFA6204

Q34237680-4B355787-86FD-4E9E-90A0-56FB8FDABFF2

Q34237680-4FAA2988-05C6-4858-9451-A76A596DA333

Q34237680-6198568E-FF12-4EBF-9A47-740C7229B95E

Q34237680-7286E6A2-BC38-4470-B6F8-BDF3EF1D6089

Q34237680-73455A98-BD56-408E-8A50-0D3B7A18661A

Q34237680-7D725650-E851-43CF-8A99-7641E56A3638

Q34237680-859C69FD-1F86-4935-ABBA-1CD09FDE508C

P304

Q34237680-48F2D2E2-DD1C-4D62-95C2-B4C65060443E

P31

Q34237680-0118B7B9-7A47-4BA7-B686-480D4C29731B

P356

Q34237680-5849D653-3382-4873-ABA6-D8AB71BE2C17

P407

Q34237680-C9D307F0-FF16-4A5A-89ED-4074214F411C

P433

Q34237680-4AB337E0-F38B-410F-813E-7AF777D23443

P478

Q34237680-AB10555F-9018-4B26-B1E1-6F1A2CB223FB

P50

Q34237680-AB9277AA-713D-4057-A0A1-1E6FF7CC5F5E

P577

Q34237680-2839E674-390C-42FE-B212-A9288D51AD8E

P5875

Q34237680-2E820153-342F-49F4-A36F-9CDFD6F07A29

P698

Q34237680-56A8E1A9-C8EF-49A5-B9CE-DDC9FE767948

P921

Q34237680-15B014B3-6689-4C66-AC9D-C5562B4FDA57

P932

Q34237680-8E891917-020C-4E87-8D36-14F605AF3D0C

P356

P1433

P1476

Residual insulin production an ...... iabetes: Joslin Medalist Study

@en

P2093

George Eisenbarth

http://www.w3.org/2001/XMLSchema#string

George L King

http://www.w3.org/2001/XMLSchema#string

Hillary A Keenan

http://www.w3.org/2001/XMLSchema#string

Jared Levine

http://www.w3.org/2001/XMLSchema#string

Jennifer K Sun

http://www.w3.org/2001/XMLSchema#string

Lloyd P Aiello

http://www.w3.org/2001/XMLSchema#string

Susan Bonner-Weir

http://www.w3.org/2001/XMLSchema#string

P2860

A genome-wide search for human type 1 diabetes susceptibility genes

Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends.

Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort).

A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 1.

Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss

Beta cell death and protection.

Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS).

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

Glucose control in the UKPDS: what did we learn?

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

P304

2846-2853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB10-0676

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Doria

P577

2010-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45603466

http://www.w3.org/2001/XMLSchema#string

P698

20699420

http://www.w3.org/2001/XMLSchema#string

P921

P932

2963543

http://www.w3.org/2001/XMLSchema#string